245 related articles for article (PubMed ID: 3702867)
21. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
22. [Isolation and characteristics of a new trypsin and chymotrypsin inhibitor from potato tubers].
Revina TA; Valueva TA; Ermolova NV; Kladnitskaia GV; Mosolov VV
Biokhimiia; 1995 Nov; 60(11):1844-52. PubMed ID: 8590757
[TBL] [Abstract][Full Text] [Related]
23. Partially folded bovine pancreatic trypsin inhibitor analogues attain fully native structures when co-crystallized with S195A rat trypsin.
Getun IV; Brown CK; Tulla-Puche J; Ohlendorf D; Woodward C; Barany G
J Mol Biol; 2008 Jan; 375(3):812-23. PubMed ID: 18054043
[TBL] [Abstract][Full Text] [Related]
24. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
Ma LC; Anderson S
Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
[TBL] [Abstract][Full Text] [Related]
25. Attempts to convert chymotrypsin to trypsin.
Venekei I; Szilágyi L; Gráf L; Rutter WJ
FEBS Lett; 1996 Jan; 379(2):143-7. PubMed ID: 8635580
[TBL] [Abstract][Full Text] [Related]
26. Distance between the basic group of the amino acid residue's side chain in position P1 of trypsin inhibitor CMTI-III and Asp189 in the substrate pocket of trypsin has an essential influence on the inhibitory activity.
Jaśkiewicz A; Lesner A; Rózycki J; Rodziewicz S; Rolka K; Ragnarsson U; Kupryszewski G
Biochem Biophys Res Commun; 1997 Nov; 240(3):869-71. PubMed ID: 9398660
[TBL] [Abstract][Full Text] [Related]
27. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition.
Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L
J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357
[TBL] [Abstract][Full Text] [Related]
28. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
Czapinska H; Helland R; Smalås AO; Otlewski J
J Mol Biol; 2004 Dec; 344(4):1005-20. PubMed ID: 15544809
[TBL] [Abstract][Full Text] [Related]
29. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
30. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
Schlott B; Wöhnert J; Icke C; Hartmann M; Ramachandran R; Gührs KH; Glusa E; Flemming J; Görlach M; Grosse F; Ohlenschläger O
J Mol Biol; 2002 Apr; 318(2):533-46. PubMed ID: 12051857
[TBL] [Abstract][Full Text] [Related]
31. Conformational stability of porcine-pancreatic secretory trypsin inhibitors (Kazal inhibitors).
Menegatti E; Tomatis R; Guarneri M; Scatturin A
Int J Pept Protein Res; 1981 Apr; 17(4):454-9. PubMed ID: 7309349
[No Abstract] [Full Text] [Related]
32. Enzyme substrate and inhibitor interactions.
Blow DM; Smith JM
Philos Trans R Soc Lond B Biol Sci; 1975 Nov; 272(915):87-97. PubMed ID: 1820
[TBL] [Abstract][Full Text] [Related]
33. High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.
Czapinska H; Otlewski J; Krzywda S; Sheldrick GM; Jaskólski M
J Mol Biol; 2000 Feb; 295(5):1237-49. PubMed ID: 10653700
[TBL] [Abstract][Full Text] [Related]
34. [Study of trypsin-substrate and trypsin-inhibitor complexes. 1. Conformation of Asp-102, His-57 and Ser-195 residues in the trypsin active center].
Godzhaev NM
Mol Biol (Mosk); 1984; 18(5):1432-5. PubMed ID: 6438492
[TBL] [Abstract][Full Text] [Related]
35. High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds.
Luckett S; Garcia RS; Barker JJ; Konarev AV; Shewry PR; Clarke AR; Brady RL
J Mol Biol; 1999 Jul; 290(2):525-33. PubMed ID: 10390350
[TBL] [Abstract][Full Text] [Related]
36. Highly effective protease inhibitors from variants of human pancreatic secretory trypsin inhibitor (hPSTI): an assessment of 3-D structure-based protein design.
Szardenings M; Vasel B; Hecht HJ; Collins J; Schomburg D
Protein Eng; 1995 Jan; 8(1):45-52. PubMed ID: 7770451
[TBL] [Abstract][Full Text] [Related]
37. Trypsin inhibitors in bovine lung and pancreas during development.
Wilusz T; Wilimowska-Pelc A; Mejbaum-Katzenellenbogen W
Acta Biochim Pol; 1976; 23(2-3):269-75. PubMed ID: 9760
[TBL] [Abstract][Full Text] [Related]
38. Reaction of lentil trypsin-chymotrypsin inhibitors with human and bovine proteinases.
Weder JK; Kahleyss R
J Agric Food Chem; 2003 Dec; 51(27):8045-50. PubMed ID: 14690394
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of trypsin by cowpea thionin: characterization, molecular modeling, and docking.
Melo FR; Rigden DJ; Franco OL; Mello LV; Ary MB; Grossi de Sá MF; Bloch C
Proteins; 2002 Aug; 48(2):311-9. PubMed ID: 12112698
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
Capasso C; Rizzi M; Menegatti E; Ascenzi P; Bolognesi M
J Mol Recognit; 1997; 10(1):26-35. PubMed ID: 9179777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
